You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca is part of a joint venture to build a $125 million plant in North Africa. The company established AstraZeneca al-Djazair, with two companies in Algeria, Salhi and Hasnaoui, to construct the facility. Algerian law requires that local companies have the majority ownership, so AstraZeneca Already a subscriber Login You have…
The company has signed an agreement for the acquisition of all shares in the Danish companies Lab-Vent Controls A/S and Koldt & Ryø El A/S. The companies are leaders on the Danish market in ventilation solutions for laboratories and cleanrooms. They will be a complement to AddLife´s operatiAlready a subscriber…
The bioink company has entered an agreement with the owners of Cytena to acquire all its shares for a purchase price of 30.25M euros. Through cytena’s complementary technology offering, Cellink sees great synergies that will support future growth. About Cytena Cytena is a life science companyAlready a subscriber Login You…
The company announced earlier this summer that it has entered into an agreement to acquire Spitfire Pharma, Inc. (Spitfire) including its product candidate SP-1373 (to be renamed ALT-801), a potent GLP-1/Glucagon receptor co-agonist for the treatment of non-alcoholic steatohepatitis (NASH). SpitfAlready a subscriber Login You have read all your free…
